Study on Anti-inflammatory Effects of Topical R115866 Gel

NCT00719121 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous Inflammation

Interventions

DRUG: Talarozole
DRUG: Differin™, 0.1% adapalene gel

Sponsor

Stiefel, a GSK Company